Cellid Co., Ltd. Logo

Cellid Co., Ltd.

Develops immunotherapeutic vaccines for cancer and infectious diseases.

299660 | KO

Overview

Corporate Details

ISIN(s):
KR7299660001
LEI:
Country:
South Korea
Address:
서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시

Description

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-09-18 00:00
소송등의제기ㆍ신청(일정금액이상의청구)
Korean HTML 8.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1015.8 KB
2025-08-12 00:00
소송등의판결ㆍ결정(일정금액이상의청구)
Korean HTML 7.0 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 28.4 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.6 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 26.2 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.6 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 26.2 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB

Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cellid Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.